Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F23820)

Formulation Name

Mirabegron 8mg/ml extended release for suspension

Company

Apgdi

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Mirabegron	DMS1GYT	Overactive bladder	GC50.0	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Acesulfame	E00341	36573	Flavoring agent
Ethylparaben	E00177	8434	Antimicrobial preservative
Hydrochloric acid	E00015	313	Acidulant
Hypromellose	E00634	Not Available	Coating agent
Magnesium stearate	E00208	11177	lubricant
Mannitol	E00103	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
methylparaben	E00149	7456	Antimicrobial preservative
Silicon dioxide	E00670	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Simethicone	E00575	6433516	Antifoaming agent; Diluent; Water-repelling agent
Xanthan gum	E00694	Not Available	Bioadhesive material; Emulsifying agent; Gelling agent; Modified-release agent; Suspending agent; Viscosity-controlling agent

--------------------